In this post, you will see a wealth of information and my views on CVSC. The reason for this is to respond to some who think that: 1) no recent information on CVSC, 2) CVSC is dead. Well, I try to show that there are reports of 2009 and even somewhat in 2010. So I also try to prove that CVSC not dead. It is very much alive. If not paid advertising, I believe answered an interest. And I think that interest is good. I hope that all information is useful for those interested in knowing CVSC.

Cardiovascular Sciences Inc, (OTC: CSVC), is an R&D stage company with ongoing research in the department of Chemistry at the University of Central Florida. After probing several technologies, one area stood out and 18 months ago, a project was launched. This has already yielded a material that promises to greatly redu...ce the clinically significant morbidity of adhesions that occur following as many as half of all surgeries in both the medical and veterinary fields. The offices of the company currently are located in the Research Park and the company is enrolled in the High-Technology Incubator program at UCF.See MoreFebruary 9, 2009 at 1:14pm ·

written by CEO:
Cardiovascular Sciences, Inc. I want to welcome all of you who are visiting this page and encourage you to sign on as a fan. We are excited about having a Facebook entry and will certainly post new developments for the company as they occur. From time to time, we will also list some exclusive notices on our health related retail site at http://www.rejuven8online.com

We are still located in the Research Park at the University of Central Florida and are still an active client company of UCF's award winning Technology Incubator. We look forward to ramping back up to full speed our research and development efforts in the area of the prevention of post-surgical adhesions and will utilize our Facebook page and other means to keep everyone informed.

Thank you for your interest and I look forward to interacting with you through Facebook.

Larry Hooper, 2/12/ 2009 8:09

http://www.facebook.com/photo.php?pi...d=123858070113

A riddle for smart people, on the splendid future of CVSC. Many well-founded indications that I've linked. Only the very smart anticipate the news. You have to read between the lines to remove the hypothesis of what is coming.

Letter to Obama, signed by Larry Hooper, along with the CEOs of the world's largest companies ( December 2009)

As CEOs of some of the world’s leading technology companies, we have an understanding of the economic
pain being felt today. We are also aware of the promise that lies across the horizon if we are strategic in
our planning. The solutions we offer below are aimed at moving us forward—towards success

http://www.techamerica.org/obama-jobs


CVSC: 10 April 2009
Revision in Authorized Shares
Current issued shares total: 16,964,134
Current share distribution among officers, directors and beneficial owners:
Individual Position
Shares Held % of Issued Shares
Eric Edelmann Executive business consultant 2,418,097 14.3%
Larry Hooper President, CEO and director 5,296,800 31.2%
Jevne Conover Director 3500 <0.1%
Sam Harder Director 3810 <0.1%
John Martin Director 50,500 0.3%
Jim Deinlein Consultant 2,108,200 12.4%
Lawrence H. Hooper, Jr., MD
CEO, Cardiovascular Sciences, Inc.
3251 Progress Dr., #A-107 ? Orlando, FL 32826 ? 407-208-9943 ? Fax: 407-207-7348

www.rejuven8online.com

CVSC

Cardiovascular Sciences, Inc. is an advanced medical device company which is developing a novel technology platform to address the problem of post-surgical and post-traumatic adhesions. Adhesions and the complications of adhesions are a significant problem worldwide for a wide range of specialists, including general surgeons, cardiothoracic surgeons, orthopedic, plastic, and ophthalmologic and otolaryngology specialists to name just some of them. In addition, the veterinary field has a tremendous need for a product that can prevent similar problems in a wide variety of animals. The Company's unique materials and processes promise a more cost-effective and decidedly more efficient and capable means to deal with a problem that has been so devastating to so many. Current sponsored research at the University of Central Florida (UCF) and previously at other institutions indicate that The Company is on the right path and progressing well.

In addition to the anti-adhesion technology, The Company owns technology in a variety of other areas, including thrombo-resistant coatings, enhanced intra-arterial balloon pumping catheters, cell engineered vascular tissues, and a method for improved recovery of the heart following cardioplegia. This yields a diversified portfolio with projects in various stages of development. www.cvsciences.org


http://www.orlandoedc.com/core/file....eCompanies.pdf

Central Florida Research Park

YouTube - Larry Hooper, MD Letter to the Editor

Cardiovascular Sciences, Inc.'s Photos - Cardiovascular Sciences, Inc. | Facebook

Press Release - Bio-Tech Medical Software, Inc. Biometrics Joins Forces with the University of Central Florida to Fight Diversion and Help Combat Prescription Narcotic Drug Abuse

CVSC - SharpCharts Workbench : StockCharts.com

Cardiovascular Sciences Inc. is a member of techamerica. Techamerca must be a very important organization. You can see for yourself. Here:
TechAmerica : Where the Future Begins - Member Directory

Larry Hooper ( CEO CVSC, COO: Bio-Tech Medical Software):
Below is a system that will close end this, save us billions in Taxes and save thousand of lives a year! Bio-Tech Medical Software, Inc. Developing State-of-the-Art Anti-Drug Diversion Software in the UCF Technology Incubator
Orlando: Bio-Tech Medical Software, Inc. is a leading developer of technology to eliminate prescription drug abuse. The Company announced today that it has been selected by the University of Central Florida’s award winning Technology Incubator to become a part of the university’s highly sophisticated and state of the art incubator program. The University Incubator’s Research Park Site Manager, Carol Ann Dykes, expressed, “We are very pleased to have Bio-Tech Medical Software, Inc. as a new client of the UCF’s Incubation Program. We are excited and look forward to the opportunity to help them rapidly grow their business.”

Under the terms of the agreement, Bio-Tech Medical Software, Inc., will utilize UCF’s Incubation Program and its elite technology in an effort to establish the most advanced prescription monitoring program for patients, physicians, and pharmacies. This system is aimed at stopping "doctor shoppers" from going to more than one doctor to obtain narcotic pain medication; thus allowing the legitimate patient to obtain their medication from legitimate providers.

Through the use of biometrics, Bio-Tech Medical Software, Inc. is taking an innovative approach to combat the ever growing problem of prescription drug abuse as well as using biometrics to prevent identity fraud which is currently used to circumvent prescription monitoring programs in 32 other states. These diverted drugs account for the statistical approximate average of seven drug related deaths that occur in Florida daily. Patients will not only benefit from faster access to their legitimate medications, but doctors and pharmacists will also benefit from greater trust ensuring their prescriptions are not stolen, diverted, or otherwise used for drug abuse. This system will help to save lives and dollars through biometrics making it the most advanced technology being offered exclusively to the State of Florida.

By utilizing the University Incubator and the expertise of the university itself, Bio-Tech Medical Software, Inc. increases its leverage to accelerate the program’s development and the company’s growth. This is another perfect example of the innovative dynamic thinking of the company’s ability to assist the public in efforts to fight against drug diversion. .
Research; www.BioScriptRx.com
Bio-Tech Medical Software, Inc.
Dr. Larry Hooper, 800-797-4711, ext#101
Source: Bio-Tech Medical Software, Inc.

Local News: West Palm Beach, Palm Beach County, Martin & St. Lucie Counties | The Palm Beach Post

Bio-Tech claims to be the only company that would meet all of the bill's requirements, including computer checks in "real time" of the fingerprints when a prescription is filled.

It is the second time in as many months in which a potential vendor played a role in crafting legislation leading to a lucrative contract.

Last month, the legislature signed off on a $10 million "economic gardening" project pushed by Gov. Charlie Crist, although a potential vendor to run the program for $1.5 million helped write the bill.

Bio-Tech uses its link with Domino and the potential Florida mandate on an Internet ad seeking $2 million in "seed money" for its "Bioscript Rx" product.

Domino, who appeared with Bio-Tech CEO Larry Hooper at a news conference Wednesday touting the bill, said he met the company's owners at a social event during the summer and was sold on the product after they demonstrated it.

Domino said he believed there was only one company that could do the job and directed questions about it to Bio-Tech's lobbyist, Jean Gonzalez

I believe that those inside can be well trusted CVSC. There are many well-substantiated evidence to believe that winning is an investment CVSC. Those who purchase at these prices, multiply their profits substantially. Think about one thing: There is evidence that Larry Hooper is very active, without giving much publicity to what he is doing, is a renowned scientist, well-connected, is closely linked with UCF, is within biotechmedical and CVSC, is perhaps the CVSC largest shareholder is a person who may be thinking about retirement. Obviously, it is logical to believe that Larry wants a retirement in style. Did he let the project CVSC drown?. No, I think not. Rather, I am inclined to think that he is preparing a big story, surprising, and when that news is published it will be too late for those who have not bought shares of CVSC. Sometimes I tend to believe that it could be a rapprochement between the two companies where Larry works. Why not?. It's possible. In that case, CVSC would become much more important, I think, because CVSC publicly traded securities and Larry is perhaps its biggest investor.

CVSC:
It not is understandable that a company with no bad results, not reporting news for a while (ie, not wanting to pay interest advertising), be punished as well. The truth is that there is enough material and recent, only that's been buried and has not circulated to reach the public. But, think a little: the CEO and board keeps all your shares. And I ask the smart people: do not make it possible for one day, unexpectedly, can make big money with these shares. Sure, for your retirement. It is an older man and the stock market is a way to earn for retirement. Larry will be working to retire in style. It's what I think. But when some people hear about this, it will be late and that shares have already CVSC, sell their shares to them. Time runs very fast. Especially for the elderly.

http://www.youtube.com/watch?v=wQ6AylJgbYo&translated=1

"2010 News

U.S. Economic Stimulus Should Focus on Small Business, Return on investment, says head of UCF Business Incubation Program

ORLANDO, Fla. (Jan. 7, 2010) --- Fact: most net new employment in the U.S. is created by small business entrepreneurs, not mega-corporations. Fact: one dollar invested in a successful business incubation program---the UCF Business Incubation Program for example---returns $5 in taxes paid by new employees of incubation client companies.

“If you study job creation and economic development it’s impossible to avoid the conclusion that incubation and economic gardening programs are America’s best hope for future economic prosperity,” said Dr. Tom O’Neal, founder and executive director of the UCF Business Incubation Program, which operates highly successful technology and business incubation facilities on the UCF campus, at Central Florida Research Park, and in Orlando, Sanford, Winter Springs, Leesburg and St. Cloud.

“Most small companies start off with one to five employees and stay that way,” Dr. O’Neal said.

“We work with small startup companies that have the most potential to grow to 100 employees or more, and our focus is on accelerating that growth curve,” he said.

Dr. O’Neal said most growth companies don’t require huge cash investments. “They need reasonable amounts of support, and they pay off in huge dividends in terms of employment, taxes and more development,” he said. “A good idea has many suitors. The U.S. private sector is eager to capitalize on bright new approaches, and the sooner we can assist small companies grow into big companies, the sooner the community benefits,” he said.

For more information about this release contact:
Dr. Tom O’Neal, Executive Director, UCF Business Incubation Program, 407 882-1120, [email protected]
Larry Vershel or Beth Payan, Larry Vershel Communications, 407-644-4142 or [email protected]

About the UCF Incubation Program:
Since its founding in 1999, the UCF Business Incubation Program has helped more than 130 emerging companies (including nearly 80 current clients) create over $500 million in annual revenue and more than 1600 new jobs with an average salary of $59,000. With six facilities across the Greater Orlando community, the Incubation Program is a collaboration in economic development between the University of Central Florida, Orange County, the City of Orlando, Seminole County, the City of Winter Springs, The City of Sanford, Lake County, the City of Leesburg, and the Florida High Tech Corridor Council. For more information, please visit www.incubator.ucf.edu."

MY OPINION: Reading this news, is it reasonable or not think CVSC?. One company included in the program. A company with development potential. Is it reasonable or not think that CVSC is supported by UCF?. I think another thing: Who will also benefit from this support?. Besides others, the shareholders also? . And who are the largest shareholders of CVSC? . I have my answers. Each one can also think of those answers ...

CVSC: Many investors are losing big money today, those who remain in CVSC not lose and, even better, we hope to earn much more. CVSC, the best value-refuge and with a wonderful appreciation potential. The clock is ticking, tomorrow may be too late. It is my opinion. But I did not lose today. The "bid", established that was uploaded. Nobody gives their shares "MM". This has to go a lot.

The "MM" have been sold under anyone and so have uploaded the "bid"? I think so. Those of us in CVSC we are uncertain about the future of CVSC. Shareholders probably sold at reasonable prices higher. I bet that only a small handful to 0.09. It is my opinion.

0.08x0.09 CVSC, that's extraordinarily good. There will come a day when the demand for shares at a price CVSC be much higher than the current offer price. It is my opinion. But when CVSC publish any news, I think many will regret not having come earlier. I, at least, I think I would regret. Many people, until five days ago, I thought I was dead CVSC!. Many thought there was no current information related CVSC!. Well, it has been since it was only a false appearance: Regarding Larry Hooper CVSC and there is enough recent information. And I wonder why there was so much interest before to make it known to all people?. I think it is clear that CVSC not want to move the stock price only with propaganda. And I think that's good, very good.

I believe that those inside can be well trusted CVSC. There are many well-substantiated evidence to believe that winning is an investment CVSC. Those who purchase at these prices, multiply their profits substantially. Think about one thing: There is evidence that Larry Hooper is very active, without giving much publicity to what he is doing, is a renowned scientist, well-connected, is closely linked with UCF, is within biotechmedical and CVSC, is perhaps the CVSC largest shareholder is a person who may be thinking about retirement. Obviously, it is logical to believe that Larry wants a retirement in style. Did he let the project CVSC drown?. No, I think not. Rather, I am inclined to think that he is preparing a big story, surprising, and when that news is published it will be too late for those who have not bought shares of CVSC. Sometimes I tend to believe that it could be a rapprochement between the two companies where Larry works. Why not?. It's possible. In that case, CVSC would become much more important, I think, because CVSC publicly traded securities and Larry is perhaps its biggest investor.

CVSC: Larry Hooper, MD- medical physician; extensive & varied clinical background; current CEO of a medical device company in the R&D stage; previously chief flight surgeon for US Air Force’s B-2 Stealth Bomber

Below is a system that will stop Pill mills on the spot! 32 states are using a data base system that doesn't work in real time and is website hosted with a user name and password! Yea.. like the doctor won't give that out! This way the real patients can get tx without having there names POSTED on a website with where they live! Read below

PRESS CONFERENCE INTRODUCTION - Rep. Domino

For years Florida has been searching for the best solution to the growing problem of prescription drug abuse that now comprises 30% of our illegal drug use and claims the life of approximately 6 Floridians each day.

In the past, there was no ideal answer since systems were too expensive, took 35 days to provide information rather than immediately in
“real time“, and created privacy and theft identity issues.

We now have technology which will do what has been done for years with license testing and other situations requiring secure information….biometric ID for the purchase of Level II-V drugs.

HB 143 (Domino) and SB 614 (Aronberg) provide an economical system to pharmacies and dispensing doctors which simply does a biometric scan, gives the scan an ID number without disclosing the name, social security number, driver’s license number, or address of the patient to anyone other than the pharmacist who already has the information. That scan then allows the pharmacist to see immediately if there have been numerous other controlled drug prescriptions already dispensed. It can also assist pharmacists and dispensing doctors in identifying a medication prescribed which will not interact well with others the patient takes.

Florida has one of the bigger problems of prescription drug abuse in the nation. This legislation will allow us to take the lead with effective technology while providing Floridians both privacy and safety.


FACTS FOR POSTERS AT PRESS CONFERENCE

Bill numbers and sponsors - HB 143 (Rep. Domino) and SB 614 (Sen. Aronberg)

Prescription drug abuse accounts for 1/3 of the illegal drug abuse nationwide and is rapidly rising to the #1 drug problem.

In 2004 48% of the drug overdose deaths (6,035) involved prescription drugs and directly caused 2,181 - approximately 6 per day.


HB 145 and SB 614 FACT SHEET

THE PROBLEM

Prescription drug abuse accounts for 1/3 of the illegal drug abuse nationwide and is rapidly rising to the #1 drug problem.

In 2004 48% of the drug overdose deaths (6,035) involved prescription drugs and directly caused 2,181 - approximately 6 per day.

In 2004, Schedule IV drugs (such as Xanax and Valium) were found to be present in more overdose deaths than cocaine.

The number of Americans who abuse controlled drugs nearly doubled from 7.8 million to 15.1 million from 19992 to 2003 and more than tripled among teens in that time.

Over the past few years, Florida has seen a high demand for prescription drugs on the street where the profit margin is high.

The majority of illegal prescription drug diversion begins with a stolen, forged, counterfeit, or altered prescription form. Patients may seek out multiple doctors to prescribe (doctor shopping), fill the same prescription at multiple pharmacies (pharmacy shopping), or present fraudulent prescriptions to pharmacies. There are also some unscrupulous physicians who simply sell prescriptions to patients (known as a drug mill).

HISTORY

In 2001 Florida passed a law making it a 3rd degree felony for doctors to write prescriptions for fictitious persons, write prescriptions solely to make money, or knowingly assist patients in fraudulently obtaining controlled substances. It also makes it a 3rd degree felony for a patient to withhold information regarding previous receipt of a prescription for a controlled substance (doctor shopping).

The National Schedules Prescription Electronic Reporting ((NASPER) Act in 2005 provided a framework and incentive for all states to establish an electronic database to monitor the prescription and use of Schedule II, III, IV and V drugs. However, lack of funding and HIPPA privacy issues have hindered the implementation.

To date roughly half the states have a monitoring program in place.

FLORIDA HAS NOT PASSED A PRESCRIPTION MONITORING BILL DUE TO COST, NO SYSTEM TO ADDRESS THE PROBLEM IN “REAL TIME” PROVIDING THE PHARMACIST/DISPENSING PHYSICIAN IMMEDIATE INFORMATION, AND PRIVACY CONCERNS. HB 145 AND SB ADDRESSES THOSE CONCERNS.
HB 143/145 AND SB 614/612

1. The War on Drugs has changed. It was focused on heroin, cocaine & marijuana in the 1980’s. Now 30% of the drug problem involves prescription drugs Prescription drug abuse is rapidly rising to #1.

2. In Florida, 8% of all prescriptions or 18 million scripts annually are written for medicines with high abuse potential.

3. In 2005, the National All Schedules Electronic Reporting (NASPER) Act was signed into law. The provisions were not funded, so only around half of states have a prescription monitoring program (PMP)

4. The current programs are little more than passive databases. Each
suspicious script must be individually queried to the database and does not interrupt drug diversion at its point of occurrence.

5. Past proposed database systems raised security & confidentiality concerns. They also did not operate in “real time” and required approximately 35 days to discover abuse.

Solution:
1. The system uses unalterable biometric data such as fingerprints which are already in frequent use for such events as license testing when privacy and security is needed and to prevent identity theft. The biometric is obtained at the time a controlled substance is dispensed, delivered or administrated to an outpatient.

2. Biometric data, prescription information & notes are sent anonymously using only an identifying ID for the print to a secure server. The patient’s privacy is completely secure.

3. The system analyzes all prescription information associated with each individual’s biometric data. An alert is generated to the pharmacist and the physician if there are changes to the script, there has been over prescribing, the patient is attempting to fill scripts from multiple providers, there are potentially adverse interactions between the various medications a single individual is taking.

4. Pilot programs are currently running successfully at 14 sites in South Florida on voluntary basis.

5. Doctor shoppers and organized prescription diversion are already being identified & prosecuted.

HB 145 and SB 614 PROVIDE THE LONG SOUGHT AFTER SOLUTION AND TECHNOLOGY FOR A SECURE AND SIMPLE SYSTEM. FLORIDA CAN NOW LEAD THE NATION IN THIS GROWING DRUG PROBLEM.


ADDITIONAL INFORMATION


COST: Approximately $300/system if implemented in volume and $150 or less per month to operate. Many financial incentives and saving to this cost are available also, such as continuing education credits. THERE IS NO REQUIRED COST TO THE STATE OF FLORIDA.

HOW WILL SURROGATES (OTHERS PICKING UP THE MEDICATION) BE HANDLED? All pharmacists currently have in place some system by which they determine to whom they will dispense. Working within that framework, the identifying code can be provided by the patient to the surrogate and then the surrogate can be given an ID. The system provides room for comments.


Consulting Team:
Louis Fischer- retired DEA pharmacist; was one of DEA’s top managers in drug diversion program; national speaker on drug abuse

Mike McManus- retired DEA investigator; was chief of DEA’s Central & South American operations; a well known speaker nationally on drug abuse

Marcella Gravalese- extensive experience in healthcare administration in Michigan & Florida; has managed programs at North Broward Hospital District and Nova SE School of Medicine

Steve Ballenger- practicing attorney experienced in health law; professor of health law at Nova SE law school

Moe Afaneh- practicing pharmacist; extensive experience in multiple types of pharmacies; owns & operates successful pharmacy in Ft. Lauderdale area

Larry Hooper, MD- medical physician; extensive & varied clinical background; current CEO of a medical device company in the R&D stage; previously chief flight surgeon for US Air Force’s B-2 Stealth Bomber

www.BioScriptRx.com

800-797-4711
954-548-7800